Frequency and severity of cirrhotic cardiomyopathy and its possible relationship with bacterial endotoxemia

Digestive Diseases and Sciences

Volumn 58, Issue 10, 2013, Pages 3029-3036

  Karagiannakis, Dimitrios S ^a   Vlachogiannakos, Jiannis ^a   Anastasiadis, Georgios ^a   Vafiadis Zouboulis, Irini ^a   Ladas, Spiros D ^a  

^a LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

Bacterial endotoxemia; Cardiomyopathy; Cirrhosis; Cytokines; LBP

Indexed keywords

CYTOKINE; LIPOPOLYSACCHARIDE BINDING PROTEIN;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; ENDOTOXEMIA; FEMALE; HUMAN; LIVER CIRRHOSIS; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; QT PROLONGATION;

ACUTE-PHASE PROTEINS; AGED; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CARRIER PROTEINS; COHORT STUDIES; CYTOKINES; ECHOCARDIOGRAPHY, DOPPLER; ENDOTOXEMIA; FEMALE; HEART ATRIA; HEMODYNAMICS; HUMANS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PREVALENCE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84885295461     PISSN: 01632116     EISSN: 15732568     Source Type: Journal    
DOI: 10.1007/s10620-013-2693-y     Document Type: Article

References (33)

1. Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rode's J. Peripheral artery vasodilatation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology. 1988;5:1151-1157.
2. Iwakiri Y, Groszmann RJ. The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule. Hepatology. 2006;43:S121-S131.
3. Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology. 2005;41:422-433.
4. Bellot P, Garcia-Pagan JC, France's R, et al. Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis. Hepatology. 2010;5:2044-2052.
5. Vlachogiannakos J, Saveriadis AS, Viazis N, et al. Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis. Aliment Pharmacol Ther. 2009;29:992-999.
6. Moller S, Henriksen JH. Cirrhotic cardiomyopathy. J Hepatol. 2010;53:179-190.
7. Alqahtani SA, Fouad TR, Lee SS. Cirrhotic cardiomyopathy. Semin Liver Dis. 2008;28:59-69.
8. Zambruni A, Trevisani F, Caraceni P, Bernardi M. Cardiac electrophysiological abnormalities in patients with cirrhosis. J Hepatol. 2006;44:994-1002.
9. Ma Z, Miyamoto A, Lee SS. Role of altered beta-adrenoceptor signal transduction in the pathogenesis of cirrhotic cardiomyopathy in rats. Gastroenterology. 1996;110:1191-1198.
10. Ma Z, Meddings JB, Lee SS. Membrane physical properties determine β-adrenergic receptor function in cirrhotic rats. Am J Physiol. 1994;267:G87-G93.
11. Gaskari SA, Liu H, Moezi L, Li Y, Baik SK, Lee SS. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Br J Pharmacol. 2005;146:315-323.
12. Liu H, Ma Z, Lee SS. Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats. Gastroenterology. 2000;118:937-944.
13. Kleber G, Braillon A, Gaudin C, Champigneulle B, Cailmail S, Lebrec D. Hemodynamic effects of endotoxin and platelet activating factor in cirrhotic rats. Gastroenterology. 1992;103:282-288.
14. Guilo P, Mansourati J, Maheu B, et al. Long-term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence. Am J Cardiol. 1997;79:1276-1278.
15. Perez-Paramo M, Munoj J, Albillos A, et al. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology. 2000;31:43-48.
16. Nagueh SF, Appleton CP, Gillebert TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr. 2009;22:107-133.
17. Achecar L, Gonzalez-Tallon A, Mesonero F, Serradilla R, Milicua JM, Ruiz-del-Arbol L. Relationship between circulatory dysfunction and severity of cardiomyopathy in patients with cirrhosis. J Hepatol. 2011;54:S61-S62.
18. Krag A, Bendtsen F, Henriksen JH, Moller S. Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites. Gut. 2010;59:105-110.
19. Nazar A, Sitges M, Guevara M, et al. Cardiomyopathy in patients with cirrhosis. Frequency, characteristics and relationship with circulatory dysfunction and prognosis. J Hepatol. 2010;53:S85.
20. Bernardi M, Calandra S, Colantoni A, et al. Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. Hepatology. 1998;27:28-34.
21. Henriksen JH, Goetze JP, Fuglsang S, Christensen E, Bendtsen F, Moller S. Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease. Gut. 2003;52:1511-1517.
22. Albillos A, De La Hera A, Gonzalez M, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology. 2003;37:208-217.
23. Rozenberg S, Besse S, Brisson H, et al. Endotoxin-induced myocardial dysfunction in senescent rats. Crit Care. 2006;10:R124.
24. Schumann RR, Latz E. Lipopolysaccharide-binding protein. Chem Immunol. 2000;74:42-60.
25. Opal SM, Scannon PJ, Vincent JL, et al. Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock. J Infect Dis. 1999;180:1584-1589.
26. Krag A, Bendtsen F, Kjaer A, Leth-Petersen C, Moller S. Cardiac function studied by dobutamine stress MRI in patients with mild cirrhosis. J Hepatol. 2009;50:S277.
27. Klein AL, Burstow DJ, Talik AJ, Zachariak PK, Bailey KR, Seward JB. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. Mayo Clin Proc. 1994;69:212-224.
28. Wong F, Villamil A, Merli M, et al. Prevalence of diastolic dysfunction in cirrhosis, and its clinical significance. Hepatology. 2011;54:475A-476A.
29. Urbano-Marquez A, Estruch R, Navarro-Lopez F, Grau JM, Mont L, Rubin E. The effects of alcoholism on skeletal and cardiac muscle. N Engl J Med. 1989;320:409-415.
30. Preedy VR, Siddiq T, Why H, Richardson PJ. The deleterious effects of alcohol on the heart: involvement of protein turnover. Alcohol Alcohol. 1994;29:141-147.
31. Harcombe AA, Ramsay L, Kenna JG, et al. Circulation antibodies to cardiac protein-acetaldehyde adducts in alcoholic heart muscle disease. Clin Sci. 1995;88:262-268.
32. Pozzi M, Carugo S, Boari G, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology. 1997;26:1131-1137.
33. Grose RD, Nolan J, Dillon JF, et al. Exercise-induced left ventricular dysfunction in alcoholic and non-alcoholic cirrhosis. J Hepatol. 1995;22:326-332.